232 related articles for article (PubMed ID: 31333097)
1. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
Borah P; Deka S; Mailavaram RP; Deb PK
Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
[TBL] [Abstract][Full Text] [Related]
2. Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.
Sousa JB; Fresco P; Diniz C; Goncalves J
Recent Pat Anticancer Drug Discov; 2018; 13(1):40-69. PubMed ID: 29119938
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors.
Jamwal S; Mittal A; Kumar P; Alhayani DM; Al-Aboudi A
Curr Pharm Des; 2019; 25(26):2892-2905. PubMed ID: 31333104
[TBL] [Abstract][Full Text] [Related]
4. A
Lambertucci C; Marucci G; Catarzi D; Colotta V; Francucci B; Spinaci A; Varano F; Volpini R
Curr Med Chem; 2022 Aug; 29(28):4780-4795. PubMed ID: 35184706
[TBL] [Abstract][Full Text] [Related]
5. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
Gorain B; Choudhury H; Yee GS; Bhattamisra SK
Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092
[TBL] [Abstract][Full Text] [Related]
6. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
7. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
Deb PK; Deka S; Borah P; Abed SN; Klotz KN
Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
[TBL] [Abstract][Full Text] [Related]
8. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.
Rivera-Oliver M; Díaz-Ríos M
Life Sci; 2014 Apr; 101(1-2):1-9. PubMed ID: 24530739
[TBL] [Abstract][Full Text] [Related]
9. Adenosine receptors as targets for therapeutic intervention.
Suvarna B
Kathmandu Univ Med J (KUMJ); 2013; 11(41):96-101. PubMed ID: 23774426
[TBL] [Abstract][Full Text] [Related]
10. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
[TBL] [Abstract][Full Text] [Related]
11. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Abbracchio MP; Cattabeni F
Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of Adenosine Receptors: The State of the Art.
Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K
Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236
[TBL] [Abstract][Full Text] [Related]
13. Molecular and Structural Insight into Adenosine A
Karati D; Mukherjee S; Roy S
Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives.
Soleimani A; Bahreyni A; Roshan MK; Soltani A; Ryzhikov M; Shafiee M; Soukhtanloo M; Jaafari MR; Mashkani B; Hassanian SM
J Cell Physiol; 2019 Mar; 234(3):2329-2336. PubMed ID: 30191994
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives.
Bahreyni A; Khazaei M; Rajabian M; Ryzhikov M; Avan A; Hassanian SM
J Pharm Pharmacol; 2018 Feb; 70(2):191-196. PubMed ID: 29057476
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological targeting of adenosine receptor signaling.
Peleli M; Fredholm BB; Sobrevia L; Carlström M
Mol Aspects Med; 2017 Jun; 55():4-8. PubMed ID: 28088486
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.
Akkari R; Burbiel JC; Hockemeyer J; Müller CE
Curr Top Med Chem; 2006; 6(13):1375-99. PubMed ID: 16918456
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in adenosine receptor ligands and their potential as novel drugs.
Müller CE; Jacobson KA
Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives.
Bahreyni A; Samani SS; Khazaei M; Ryzhikov M; Avan A; Hassanian SM
J Cell Physiol; 2018 Apr; 233(4):2733-2740. PubMed ID: 28661026
[TBL] [Abstract][Full Text] [Related]
20. A1 adenosine receptors and their ligands: overview and recent developments.
Müller CE
Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
